Follow us on
Search
Close this search box.

ENGIN CELIK (M) (G)

Dr. Engin Celik, Gynecologic Oncologist

ENGIN CELIK (M) (G)

Snapshot Highlights

  • Specialist in Gynecologic Oncology and Obstetrics & Gynecology.
  • Extensive experience in advanced gynecological oncology surgery.
  • Published research in leading medical journals on endometrial cancer and gynecological procedures.
  • Affiliated with prestigious medical societies including ESGO, SGO, and MIJOD.

Professional Experience

Dr. Engin Celik brings over a decade of dedicated experience in Obstetrics and Gynecology, with a specialized focus on Gynecologic Oncology. His professional journey includes significant tenures at reputable institutions, demonstrating a commitment to advancing women’s health and combating gynecologic cancers.

  • Current practice at Acıbadem Health Group (2023-Present).
  • Served at Istanbul Kanuni Sultan Suleyman Training and Research Hospital (2019-2023).
  • Advanced training and practice in Gynecological Oncology Surgery at Istanbul University Istanbul Faculty of Medicine (2016-2019).
  • Gained valuable experience at Istanbul Kanuni Sultan Suleyman Training and Research Hospital (2014-2016).
  • Practiced at Kutahya Evliya Celebi Training and Research Hospital (2012-2014).
  • Completed compulsory service at Kayseri Develi State Hospital (2011-2012).
  • Foundation of his specialization in Obstetrics and Gynecology at Istanbul University Istanbul Faculty of Medicine (2005-2010).

Education

Dr. Celik’s robust educational background forms the bedrock of his expertise in Gynecologic Oncology and Obstetrics and Gynecology.

  • Completed Gynecological Oncology Surgery fellowship at Istanbul University Istanbul Faculty of Medicine (2019).
  • Earned his specialization in Obstetrics and Gynecology from Istanbul University Istanbul Faculty of Medicine (2010).
  • Received his medical degree from Hacettepe University Faculty of Medicine (2005).

Memberships

As a respected member of leading professional organizations, Dr. Celik stays at the forefront of advancements in gynecologic oncology and obstetrics.

  • The European Society of Gynaecological Oncology (ESGO)
  • Minimally Invasive Gynecological Oncology Association (MIJOD)
  • Turkish Gynecological Oncology Society (TRSGO)
  • Society of Gynecologic Oncology (SGO)
  • Turkish Society of Gynecology and Obstetrics (TRSGO)

Publications

Dr. Celik is an active contributor to the medical literature, with a portfolio of published research focusing on critical aspects of gynecologic health and cancer prognosis.

  • Investigated the impact of adenomyosis on endometrial cancer in a university hospital-based cohort study (Journal of Obstetrics and Gynaecology, 2021).
  • Examined the effect of time to surgery on endometrial cancer prognosis (Gynecology Obstetrics & Reproductive Medicine, 2021).
  • Researched the correlation between visceral adiposity and survival outcomes in endometrial cancer patients (J Obstet Gynaecol Res, 2021).
  • Studied the influence of endometriosis on survival in women with synchronous endometrial and ovarian cancer (Journal of Endometriosis and Pelvic Pain Disorders, 2019).
  • Contributed research on predicting vaginal delivery using transperineal ultrasound in induced labor (International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2018).
  • Evaluated biochemical hyperandrogenism in adolescent girls with menstrual irregularities (Journal of Medical Biochemistry, 2018).
  • Authored studies on risk factors for surgical site infection after hysterectomy (Journal of Infections in Developing Countries, 2017).
  • Explored differences in patients with primary versus recurrent endometriomas (Istanbul Medical Journal, 2017).
  • Addressed the necessity of blood transfusion in disseminated intravascular coagulation associated postpartum hemorrhage (Journal of Maternal-Fetal Neonatal Medicine, 2017).
  • Contributed to the understanding of different surgical techniques in tubo-ovarian abscess management (Gynecology Obstetrics and Reproductive Medicine, 2017).